Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | 0.00% | 0.00% | -76.92% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Capitalization 1 | 1.567 | 5.851 | 1.149 |
Enterprise Value (EV) 1 | 1.232 | 5.55 | 2.421 |
P/E ratio | - | -0.87 x | -1.92 x |
Yield | - | - | - |
Capitalization / Revenue | - | - | - |
EV / Revenue | - | - | - |
EV / EBITDA | - | - | - |
EV / FCF | - | - | -3,225,410 x |
FCF Yield | - | - | -0% |
Price to Book | - | 3.52 x | 0.98 x |
Nbr of stocks (in thousands) | 1,044,861 | 1,044,861 | 1,044,861 |
Reference price 2 | 0.001500 | 0.005600 | 0.001100 |
Announcement Date | 7/11/22 | 7/11/22 | 10/17/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | - | - |
EBIT 1 | -0.9131 | -1.109 | -0.5744 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -0.9131 | -1.109 | -0.5986 |
Net income 1 | -0.9131 | -1.109 | -0.5986 |
Net margin | - | - | - |
EPS | - | -0.006456 | -0.000572 |
Free Cash Flow | - | - | -0.7506 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 7/11/22 | 7/11/22 | 10/17/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | - | - | 1.27 |
Net Cash position 1 | 0.33 | 0.3 | - |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | - | -0.75 |
ROE (net income / shareholders' equity) | - | -81.1% | -54.3% |
ROA (Net income/ Total Assets) | - | -50.4% | -20% |
Assets 1 | - | 2.2 | 2.986 |
Book Value Per Share | - | 0 | 0 |
Cash Flow per Share | - | 0 | 0 |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 7/11/22 | 7/11/22 | 10/17/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- LEAS Stock
- Financials ANEW MEDICAL, INC.